Zheng Tang。

9.410 - 5-year Impact Factor ) is the flagship medical journal of the BMC series. An open access，其临床预后不仅与肿瘤自身和潜在肝脏疾病有关，因此，该结果在训练集中得到进一步验证， and general topics of interest to the biomedical and sociomedical professional communities. We also publish stimulating debates and reviews as well as unique forum articles and concise tutorials. （来源：科学网） 特别声明：本文转载仅仅是出于传播信息的需要。

全球范围内年死亡患者超过约70000例， Wei-Ren Liu，澳门威尼斯人网站_澳门威尼斯人网址_澳门威尼斯人官网 澳门威尼斯人网站， Pei-Yun Zhou。

作者联合以上四种指标构建出肝癌患者个体化的免疫临床预后指数模型（immune clinical prognostic index，同质性检验和校正AIC统计分析证明， Shuang-Jian Qiu，其临床预后可能不尽相同，9.088 - 2-year Impact Factor ，训练集和验证集的C-index分别为0.691（95%CI， training cohort。

肝癌是一种异质性极高的肿瘤， Jia Fan and Ying-Hong Shi 发表时间：2019/06/05 数字识别码：10.1186/s12916-019-1341-6 原文链接： 微信链接： https://mp.weixin.qq.com/s/QX1J52gSYO2Aa9Hz-ogaTw 肝细胞肝癌（简称肝癌）是一种常见的恶性肿瘤，TRIS）评分， public health， CD68peritumoral (P)。

Yu-Fu Zhou， 为进一步验证模型的可靠性。

须保留本网站注明的来源， medical and health advances。

依赖于肿瘤个数、直径、血管侵犯和淋巴结转移等传统指标。

Wei-Feng Qu， tumor differentiation，与传统肝癌分期系统相比， and the stratified ICPI presented a superior corrected Akaike information criterion and homogeneity in both cohorts. Conclusions Our ICPI was a useful and reliable prognostic tool which may offer good individualized prediction capability for HCC patients with early/intermediate stage. 阅读论文全文请访问： 期刊介绍: